EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Anti‐tumor effect of Japanese herbal medicine Ninjinto in mouse melanoma: Efficacy of preventive treatment

Noriaki Nakai, Tsunao Kishida, Norito Katoh

Traditional & Kampo Medicine · 2015

DOI: 10.1002/tkm2.1010 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Aim We evaluated the anti‐tumor effect of the Japanese herbal medicine Ninjinto in a mouse melanoma. Methods In in vitro experiments, B16F1 melanoma cells were cultured alone or in the presence of Ninjinto. Cell count, viability, concentration of interleukin ( IL )‐4 and 6, interferon ( IFN )‐γ in the medium, IL ‐6 messenger RNA level in cells, and morphological changes were assessed. In vivo , approximately 5 × 10 5 B16F1 cells in 50 μL phosphate‐buffered saline were injected s.c. into the flank of C57BL /6 mice that had received plain drinking water or water containing 4 mg/mL of Ninjinto for 1 month. Tumor volume was measured using digital calipers. The presence of immune cells and expression of CD4 , Foxp3 , and IFN ‐γ at the site of the tumor were investigated on immunohistochemistry. Results In vitro , Ninjinto induced apoptosis with decreased production of IL ‐6 protein. Preventive oral Ninjinto treatment tended to suppress growth of B16F1 tumors in mice, with an increased tumor necrosis area, increased infiltration of mononuclear cells, neutrophils, CD4 + cells, and IFN ‐γ+ cells, and reduced infiltration of Foxp3 + cells at the site of tumor. Conclusion Ninjinto showed anti‐tumor efficacy against B16F1 melanoma in vitro and in vivo . The significant enhancement of innate immunity and CD4 T ‐cell immune response, and the improved immune tolerance suggest induction of effective anti‐tumor immune responses.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →